This 22-year-old startup founder got his college to pay him $200,000: 'Sometimes, you just have to ask'
But startup founder Emil Barr says everything is negotiable — even your college tuition.
In fact, on top of successfully negotiating with his school administration to cover about $60,000 of his tuition fees, the 22-year-old startup founder made more than $140,000 over the four-year period that he was enrolled, according to documents reviewed by CNBC Make It.
By the time he graduated, Barr had been paid over $200,000 by Miami University.
He said he learned the art of negotiation through his experience as an entrepreneur.
During his freshman year at Miami University, Barr built his first startup, a social media marketing agency called Step Up Social.
He entered university with a scholarship that covered only part of his tuition. By his sophomore year, Barr used his entrepreneurial experience as leverage and convinced his school administration to fund the rest of his tuition
At the time, he said, the university was making a concerted effort to attract more donors, and as part of that, was focused on developing and strengthening its entrepreneurship program on campus.
"[But] the one downside is there weren't that many student-run businesses at the college for them to talk about," he said. As a result, Barr said, he often spent time speaking with donors they brought on campus, as well as with the university press outlet.
"Towards the end of my second year at Miami, that's when we really started to have these conversations, because the business had gone somewhere. We had done over a million dollars in revenue," Barr said.
"So I sat down with the dean, and I was like: 'Look ... I'm spending a lot of time doing this. I feel like I'm [creating] a lot of value for the school, and yet I'm still paying for [some of] my own tuition and working side jobs to try to make that happen," Barr said.
In December 2022, he negotiated a financial package that fully covered his tuition.
Barr also won multiple on-campus startup pitch competitions and student grants which earned him more than $30,000 throughout his time at the university, according to documents reviewed by CNBC Make It.
By the time his junior year rolled around, Barr had also brought on the university as a client of his business. In total, he made over $100,000 in revenue through the university's contracts with Step Up Social.
But one of his "crowning accomplishments," Barr said, was not the financial payouts — but instead being the only student on campus who was given a faculty parking pass.
"I fought for that for nine months ... people still joke about it, because I was so determined," he said.
Step Up Social has since acquired and rebranded to Candid Network, an online marketing agency specializing in user-generated content. Barr said he's in the process of selling the business.
While it's become trendy for startup founders to drop out of school to build their businesses full-time, Barr found a way to stay enrolled — and profit from it, all while building a business from the ground up. One skill that has helped him over the years is learning how to ask for things.
"What [I] learned is a lot of the things that people are scared to ask for — really, you can get them. Sometimes, you just have to ask," Barr said.
He said a big part of negotiation is simply finding out what is valuable to the other side, and adjusting from there. "I think that so often people just assume," he said. Instead of guessing, he suggested being genuine and asking the other side what they want to get out of the situation.
"Everyone always has an angle or an end game, which sounds a little bit cynical. I think that a way you [can] overcome that cynicism is just ask: 'What would make you happy?' And then you have a starting point," Barr said.
He graduated from Miami University in 2024 and is set to join Stanford's Graduate School of Business as a deferred admit in September 2027.
Today, Barr also runs the workforce development platform Flashpass, a business he co-founded in 2022. Flashpass brought in $1 million in revenue in 2024 and another $1 million year-to-date, according to documents reviewed by CNBC Make It.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
3 hours ago
- CNBC
30-year-old worth $700,000 shares 4 spending habits she avoided in her early 20s: 'I don't have any regrets'
Personal finance consultant Michela Allocca made some financial sacrifices in her 20s, and she has no regrets. At age 30, Allocca has a net worth of more than $700,000 according to documents reviewed by CNBC Make It. In her experience, you sometimes need to make temporary sacrifices to stay grounded financially, even when it feels like everyone else is spending, she says. "We act like not having these things in our early 20s means we're never going to have them," says Allocca, the Chicago-based author of "Own Your Money." But often, "they're status signal things," rather than things people "genuinely and sincerely care about," she tells CNBC Make It. Holding off on certain expenses early in her career helped her stay on track financially, Allocca wrote in a recent LinkedIn post that detailed four financial habits she avoided in her own early 20s. Here are those habits, and what she did instead: The social pressure to travel in your 20s can be strong, whether to become more worldly or simply because it seems like everyone else is doing it, says Allocca. Many young people take big trips right after college, often with little thought about whether it's affordable because they believe, "well, money will always come," she notes. Even a budget-conscious trip can cost $1,000 to $2,000, an expense that's particularly hard to justify early in your career when you're earning a low salary, says Allocca. A single trip can cost as much as an entire month's rent: Gen Z spends an average of $1,600 per month on rent, according to data published in January by credit firm Allocca was 22 and earning $60,000 per year in Boston, flights in particular felt expensive relative to her income, so she focused on taking affordable, domestic trips, she says. While she began taking bigger trips by her late 20s — including a recent visit to Japan — she says they were planned and budgeted for well in advance. While she now travels on her own terms, she says it's "both normal and OK" for people in their 20s to hold off until they can afford the expense. "If I am going to go on a vacation, it has to be something that I actually want to go on, not because I'm feeling pressured to go somewhere," she says. Whether it was sharing one bathroom with three other roommates or moving back in with her parents during the Covid-19 pandemic, Allocca chose not to live alone for most of her 20s. "I was able to continue to save, on average, about $1,000 a month because I wasn't dumping all my money into rent. And that actually really helped me get ahead" on investments, she says. Social media can create unrealistic expectations for what early-career earners can afford, says Allocca. In large cities like San Francisco or New York, residents need to earn more than $100,000 annually to keep rent below the commonly recommended 30% of their budget, according to a Zillow report published in May. "I feel bad for Gen Z, because their perception of what's normal at their age is so warped," she says. "There's all this [online] pressure for young people to live in a high-rise or live alone in these major cities, and it's just not reasonable." At age 27, Allocca finally decided to live alone in a nicer apartment with more space and amenities. She needed a home office, and by that point, knew her income could support a roughly $1,000-per-month rent increase without derailing her financial goals, she says. Allocca took a minimalist approach to her wardrobe in her early 20s, often buying the same pieces in different colors and sticking to a few signature shades so everything was easy to mix and match, she says. She shopped mostly at inexpensive stores like Primark and Old Navy, she adds. "When you have a general color scheme, you can match your clothes easier," says Allocca. "It also helps eliminate the paradox of choice." Her approach kept her clothing costs low. "I wasn't prioritizing shopping as part of my budget," Allocca says. "If I did need to buy something, I was going to those really inexpensive stores so I could get the least expensive version possible." Today, she uses the same principles for what she calls a capsule wardrobe of "elevated basics" — versatile pieces that work with most of what she already owns, she says. She's now more willing to spend money on better quality that she knows will last for years, she adds — like a roughly $450 cashmere sweater that's currently the most expensive item in her closet. In her 20s, Allocca avoided spending on things she could easily do herself. When her walk to work was about 30 minutes, she'd make the trip on foot rather than paying for a ride or public transit, she says. "I didn't take any unnecessary Ubers, I never ordered delivery," she wrote on LinkedIn. Many people justify convenience purchases by thinking "my time is so valuable." Allocca didn't see it that way, she says: "The time that I was saving, I wasn't doing anything valuable with it. So what difference does it make if I spend the 10 extra minutes to go walk and pick up my dinner?" She only ordered out from restaurants within walking distance, she notes. "If I'm not willing to go pick it up, then I'm not ordering it out, I'm cooking at home" she says. "To me, it's creating some parameters around, 'Is this reasonable?'" Even today, Allocca rarely allows herself to pay for convenience, and only in "extenuating circumstances," she says — like paying for delivered groceries after coming home from a long trip. By consistently avoiding most convenience costs, from rides to delivery fees, she says she's freed up around $200 per month. When paired with her low rent, that money "made a big difference" in her ability to save in her 20s, she says. And while she sacrificed some comfort in her 20s, "when I look back at all of these things, I don't have any regrets," she says.
Business Wire
a day ago
- Business Wire
Atara Biotherapeutics Announces Second Quarter Financial Results and Operational Progress
THOUSAND OAKS, Calif.--(BUSINESS WIRE)-- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported financial results for the second quarter 2025 and business updates. Tabelecleucel (tab-cel ® or Ebvallo™) for Post-Transplant Lymphoproliferative Disease (PTLD) The U.S. Food and Drug Administration (FDA) has accepted the filing of Atara's Biologics License Application (BLA) for tabelecleucel (tab-cel ®) indicated as monotherapy for treatment of adult and pediatric patients two years of age and older with Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD) who have received at least one prior therapy. There are no FDA approved therapies in this treatment setting. The BLA has been granted Priority Review with a Class 2 Resubmission Prescription Drug User Fee Act (PDUFA) target action date of January 10, 2026. In July, the Company completed transferring substantially all operational activities and associated costs related to tab-cel to Pierre Fabre Laboratories. The sponsorship of the BLA continues to be maintained by the Company. Corporate Updates Strategic Options Evaluation: In April 2025, the Company temporarily paused its review of strategic alternatives pending resubmission of the tab-cel BLA. The Company has resumed its evaluation of strategic options following the resubmission of the tab-cel BLA. These options may include, but are not limited to, an acquisition, merger, reverse merger, other business combinations, licensing, sale of assets, or other strategic transactions. It is possible that Atara may not pursue a strategic alternative or transaction or that any strategic alternative or transaction, if pursued, will not be completed on attractive terms, or that a strategic alternative or transaction may not ultimately be consummated. Financial Update: Second Quarter 2025 Financial Results: Cash, cash equivalents and short-term investments as of June 30, 2025, totaled $22.3 million, as compared to $13.8 million as of March 31, 2025 Net cash used in operating activities was $7.4 million for the second quarter 2025, as compared to $10.6 million in the same period in 2024 Total revenues were $17.6 million for the second quarter 2025, as compared to $28.6 million for the same period in 2024. Total revenues decreased by $11.0 million year-over-year, primarily due to the accelerated recognition of deferred revenue in the first quarter 2025 following the transition of manufacturing responsibilities to Pierre Fabre Laboratories. As a result, less deferred revenue remained available for recognition in the comparative period. Total costs and operating expenses include non-cash stock-based compensation, depreciation and amortization expenses of $3.0 million for the second quarter 2025, as compared to $7.7 million for the same period in 2024 Research and development expenses were $7.3 million for the second quarter 2025, as compared to $33.3 million for the same period in 2024 Research and development expenses include $0.7 million of non-cash stock-based compensation expenses for the second quarter 2025, as compared to $3.3 million for the same period in 2024 General and administrative expenses were $6.5 million for the second quarter 2025, as compared to $8.9 million for the same period in 2024 General and administrative expenses include $2.1 million of non-cash stock-based compensation expenses for the second quarter 2025, as compared to $3.0 million for the same period in 2024 Atara reported net income of $2.4 million, or $0.20 basic earnings per share and $0.19 diluted earnings per share for the second quarter 2025. The net income position is due to the acceleration of revenue recognized following the transition of tab-cel development and safety responsibilities to Pierre Fabre Laboratories in July 2025 2025 Outlook and Cash Runway: Under its commercialization agreement with Pierre Fabre Medicament, Atara is eligible to receive a $40 million milestone payment upon FDA approval of the tab-cel BLA. In addition, Atara will be eligible to receive double-digit tiered royalties as a percentage of net sales and milestones related to commercial sales of EBVALLO. We anticipate the full-year 2025 operating expenses will decrease by at least 60% compared to 2024, driven by the transition of substantially all tab-cel activities and associated costs to Pierre Fabre Laboratories as well as the implementation of operational efficiencies in the first half of the year. Atara projects that cash, cash equivalents and short-term investments as of June 30, 2025, combined with the proceeds of the milestone payment upon tab-cel BLA approval under its commercialization agreement with Pierre Fabre Medicament, will provide significant cash runway and flexibility for the company to execute on its strategic priorities. About Atara Biotherapeutics, Inc. Atara is harnessing the natural power of the immune system to develop off-the-shelf cell therapies for difficult-to-treat cancers and autoimmune conditions that can be rapidly delivered to patients from inventory. With cutting-edge science and differentiated approach, Atara is the first company in the world to receive regulatory approval of an allogeneic T-cell immunotherapy. Our advanced and versatile T-cell platform does not require T-cell receptor or HLA gene editing and forms the basis of a diverse portfolio of investigational therapies that target EBV, the root cause of certain diseases. Atara is headquartered in Southern California. For more information, visit and follow @Atarabio on X and LinkedIn. Forward-Looking Statements This press release contains or may imply 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. For example, forward-looking statements include statements regarding: (1) the development, timing and progress of tab-cel, including the timing for FDA review of the resubmission of the BLA, the potential characteristics and benefits of tab-cel, and the results of, and prospects for, the global partnership with Pierre Fabre Medicament involving tab-cel, and the potential financial benefits to Atara as a result of the global partnership with Pierre Fabre Medicament, including the receipt, timing and amount of any payments to be received by Atara thereunder; (2) Atara's cash runway, receipt of potential milestone payments, and estimated reduction in operating expenses; and (3) Atara's evaluation of strategic alternatives and ability to consummate one or more strategic transactions. Because such statements deal with future events and are based on Atara's current expectations, they are subject to various risks and uncertainties and actual results, performance or achievements of Atara could differ materially from those described in or implied by the statements in this press release. These forward-looking statements are subject to risks and uncertainties, including, without limitation, risks and uncertainties associated with the costly and time-consuming pharmaceutical product development process and the uncertainty of clinical success; risks related to FDA's review of the resubmitted BLA for tab-cel; our ability to access capital, and the sufficiency of Atara's cash resources and access to additional capital on favorable terms or at all; the timing of the strategic review process; whether Atara will pursue any strategic alternatives; in the event Atara pursues a strategic alternative, that the strategic alternative may not be attractive or ultimately consummated; whether any strategic alternative will result in additional value for Atara and its stockholders; whether the process will have an adverse impact on Atara and other risks and uncertainties affecting Atara, including those discussed in Atara's filings with the Securities and Exchange Commission, including in the 'Risk Factors' and 'Management's Discussion and Analysis of Financial Condition and Results of Operations' sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings and in the documents incorporated by reference therein. Except as otherwise required by law, Atara disclaims any intention or obligation to update or revise any forward-looking statements, which speak only as of the date hereof, whether as a result of new information, future events or circumstances or otherwise. ATARA BIOTHERAPEUTICS, INC. Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (In thousands, except per share amounts) Three Months Ended June 30, Six Months Ended June 30, 2025 2024 2025 2024 Commercialization revenue $ 17,575 $ 28,640 $ 115,724 $ 55,997 Costs and operating expenses: Cost of commercialization revenue 554 4,627 20,993 6,612 Research and development expenses 7,310 33,332 34,743 78,838 General and administrative expenses 6,514 8,912 17,989 20,025 Total costs and operating expenses 14,378 46,871 73,725 105,475 Income (loss) from operations 3,197 (18,231 ) 41,999 (49,478 ) Interest and other income (expense), net (807 ) (818 ) (1,599 ) (1,299 ) Loss before provision for income taxes 2,390 (19,049 ) 40,400 (50,777 ) Provision for income taxes 3 — 3 24 Net income (loss) $ 2,387 $ (19,049 ) $ 40,397 $ (50,801 ) Other comprehensive gain (loss): Unrealized gain (loss) on available-for-sale securities — 41 (8 ) 190 Comprehensive income (loss) $ 2,387 $ (19,008 ) $ 40,389 $ (50,611 ) Basic net income (loss) per common share $ 0.20 $ (3.10 ) $ 3.52 $ (8.64 ) Diluted net income (loss) per common share $ 0.19 $ (3.10 ) $ 3.49 $ (8.64 ) Basic weighted-average shares outstanding 12,197 6,143 11,484 5,883 Diluted weighted-average shares outstanding 12,310 6,143 11,576 5,883 Expand
Miami Herald
a day ago
- Miami Herald
Layoffs? Price increases? Companies make hard choices as Trump's tariffs set in.
Barry Barr has taken a number of cost-saving measures in recent months to keep his outdoor apparel company afloat during President Donald Trump's destabilizing trade war. He froze his spending on marketing and even prohibited his employees from traveling to see customers. But while he waited for Trump's tariffs to come into better focus, he resisted making more consequential decisions at his company, KAVU True Outdoor Wear. He didn't raise prices on its fall lineup. He continued manufacturing bags, woven shirts, polar fleeces and other items at factories in China, India and Vietnam, even though Trump had signaled that those countries would face stiff duties. 'It's a sit and wait, honestly,' he said last month. 'We just don't know.' More recently, Barr was trying to wrap his head around the punishing new tariffs that were set to click on shortly after midnight Thursday. It was hard for him to know whether the slate of duties on about 90 countries would ultimately hold, given the ever-evolving nature of Trump's trade policy. On Wednesday, Trump signed an executive order that would double tariffs on India, to 50%, beginning this month in an effort to stop the country from buying Russian oil. He also threatened to impose a 100% tariff on foreign semiconductors. The latest tariff orders confirmed for Barr that he would have to raise prices and lay off employees in the months ahead. 'There will be some tough decisions to be made for sure,' he said. 'You have to put your big-kid pants on and do it.' Barr's thinking is emblematic of the shift in strategy occurring at companies across the country. For manufacturers, retailers and other businesses that rely on imported goods, Trump's tariff policy has become an exercise in forbearance. Since the spring, companies have had to contend with a series of delays, fresh threats and haphazard deals that have scrambled their ability to make long-term decisions. 'We kind of saw this summer as a holding period for a lot of firms,' said Courtney Shupert, an economist at MacroPolicy Perspectives. 'Firms were saying, 'Let's wait and see if demand is going to be stronger or weaker.'' But now that many of Trump's tariffs have officially set in and his trade policy seems to be solidifying, many companies are concluding that they can no longer afford to hold back. On recent earnings calls with investors, public companies including shopping conglomerate QVC Group, footwear brand Allbirds and eyewear vendor Warby Parker openly talked about their tactics to handle the escalating tariff costs, including increasing prices. 'I think we can, over the medium term, mitigate the impact of tariffs,' Andrew Rees, CEO of the footwear brand Crocs, said Thursday. He outlined plans to raise prices, reduce business expenses and wring savings out of the company's supply chain, including by negotiating with factories. How quickly businesses act could have wide-ranging implications for the economy. Should more companies decide to pass on price increases to consumers, that could push up inflation and chill consumer spending. Many companies in recent months also hesitated to fire, or hire, workers amid the tariff unpredictability, reminiscent of the labor hoarding after the worst of the pandemic. If companies begin to have more confidence in the tariff rates, that moratorium could break. Indeed, the latest jobs report from the Labor Department, which was released Aug. 1, suggested that businesses might be closer to that tipping point than previously thought. 'As policy is resolved, if tariffs are biting more than firms were expecting, that could be impactful for their hiring decisions,' Shupert said. Officials at the Federal Reserve are closely watching inflation and the labor market for signs that the tariffs are affecting the broader economy, even as many forecasters acknowledge that it could be some time before the full effects are known. 'These tariff shocks are unlike anything that we've seen in 100 years, virtually,' Neel Kashkari, president of the Federal Reserve Bank of Minneapolis, said in an interview on CNBC on Wednesday. 'And it's taken a while for businesses to try to process it.' In several interviews by phone and text message in recent days, Barr, who started KAVU in 1993, recounted how his business had contended with mounting pressure because of Trump's tariff policy. Barr has long paid some levies on products. But the extra tariffs that Trump revealed in April, which included since-modified duties of 46% on Vietnam and 26% on India, were much more onerous. At first, Barr chose to swallow Trump's baseline 10% tariff, as well as tariffs against China that had already kicked in. But as the trade war dragged on, he started to consider other solutions. 'There's absolutely no way I can make a profit this year absorbing all these tariffs,' Barr said. 'It's bigger than any tax bill I've had to pay.' His foreign suppliers lowered their prices slightly to account for the cost of the tariffs, which helped somewhat. Barr weighed manufacturing some items in a factory his company works with in Seattle but decided against it, in part because it would be too expensive and impractical to import the sewing machines he would need. He was also concerned that the tariffs would make buying fabric and other raw materials from abroad too costly. He is looking into whether he could move some production to factories in Central America but is not yet sure it will be possible. As the tariff landscape began to take firmer shape, however, Barr started to enact deeper changes. He chose not to raise prices on items in KAVU's fall lineup, even though the items were subject to some tariffs when they arrived in the United States this summer. But the persistently high tariff rates compelled him to increase prices for next year. KAVU products are sold in about 2,000 U.S. retail locations. The company also exports its goods to 26 countries. Working off the assumption that tariffs for Vietnam and India would settle around 10%, and China around 37.5%, Barr increased retail prices for his company's summer 2026 line by about 15% to 30% -- the most he believed customers would pay. Under the new pricing, the retail cost of a pullover made in China would rise to $120 from $90. A button-down shirt produced in India that used to retail for $80 would be $105. But with the tariff rates settling higher, Barr is now worried he will have to raise prices even more. The U.S.' trade deal with Vietnam, for instance, stipulates a 20% tariff on goods from the country, and India is facing 50% tariffs. At the same time, KAVU's preseason sales for next summer came in 15% lower compared with sales for this summer season. With his profit margin shrinking and business expenses already shaved to the bone, Barr said he would probably have to lay off some of his 28 employees in the next three to four months. 'You've got to save money somewhere so the company can move ahead,' he said. Frustrated, Barr has been speaking to members of Congress about the effect of Trump's trade policy on small businesses like his. 'What we need to thrive is stability and not chaos,' Barr said during a virtual news conference with Sen. Patty Murray, D-Wash. And while he still fears that the tariffs will severely hurt KAVU, he hopes his company can pull through with the right adjustments. 'We can fight hard to survive,' Barr said. 'That's all we can do.' This article originally appeared in The New York Times. Copyright 2025
